Drs. D. Yilmaz

Drs. D. (Dilek) Yilmaz is sinds 2018 in opleiding tot cardioloog aan het Leids Universitair Medisch centrum en zal haar opleiding begin 2025 afronden.

Daarvoor deed zij onderzoek naar Implanteerbare Cardioverter-defibrillatoren (ICD’s), dat zij naast de opleiding voortzet in het kader van haar  promotieonderzoek. Tijdens dit onderzoek heeft zij onder andere bijgedragen aan de ontwikkeling van de ICD Keuzehulp, die patiënten helpt in hun besluitvorming.

Lees hier meer over De Keuzehulp. 

Top-cited publications

117 times cited (±14/year) Source: EuropePMC

ACS chemical biology, Volume 9, Issue 8, 17 3 2014, Pages 1788-1798 Phytochemicals perturb membranes and promiscuously alter protein function. Ingólfsson HI, Thakur P, Herold KF, Hobart EA, Ramsey NB, Periole X, de Jong DH, Zwama M, Yilmaz D, Hall K, Maretzky T, Hemmings HC, Blobel C, Marrink SJ, Koçer A, Sack JT, Andersen OS. Abstract


78 times cited (±4/year) Source: EuropePMC

Journal of bone and mineral metabolism, Volume 23, Issue 6, 1 1 2005, Pages 476-482 Bone mineral density in girls and boys at different pubertal stages: relation with gonadal steroids, bone formation markers, and growth parameters. Yilmaz D, Ersoy B, Bilgin E, Gümüşer G, Onur E, Pinar ED. Abstract


68 times cited (±11/year) Source: EuropePMC

Journal of the American College of Cardiology, Volume 68, Issue 19, 1 1 2016, Pages 2047-2055 Long-Term Clinical Outcomes of Subcutaneous Versus Transvenous Implantable Defibrillator Therapy. Brouwer TF, Yilmaz D, Lindeboom R, Buiten MS, Olde Nordkamp LR, Schalij MJ, Wilde AA, van Erven L, Knops RE. Abstract


Most recent publications

16 Jan 2023

Brazilian oral research, Volume 36, 16 3 2023, Pages e140 Evaluation of the predictors of oral health-related quality of life among 3-5-year-old children with dental trauma. Tabakcilar D, Peker K, Yilmaz DO, Kasimoglu Y, Tuna-Ince EB, Gencay K, Seymen F. Abstract


06 Jan 2023

Acta physiologica (Oxford, England), 6 1 2023, Pages e13927 Furosemide rescues hypercalciuria in familial hypomagnesaemia with hypercalciuria and nephrocalcinosis model. Kriuchkova N, Breiderhoff T, Müller D, Yilmaz DE, Demirci H, Drewell H, Günzel D, Himmerkus N, Bleich M, Persson PB, Mutig K. Abstract


05 Jan 2023

Journal of periodontology, 5 1 2023 Salivary macrophage activation-related chemokines and mitogen-activated kinase kinase (MAPKK)-degrading proteolytic activity in type 1 diabetes mellitus. Yilmaz N, Polat R, Gürsoy M, Kaman W, Gül Aydin E, Fteita D, Yilmaz D, Bikker F, Gürsoy UK. Abstract